Industries we serve
Where chemistry meets regulation.
Each sector has its own evidence rules, authorities and unwritten conventions. We bring sector-specific judgement — not a generalist's checklist.
Each sector has its own evidence rules, authorities and unwritten conventions. We bring sector-specific judgement — not a generalist's checklist.
REACH and UK REACH registrants navigating dossier evaluation, substance evaluation, and the rising bar for endocrine, PMT and PBT assessment. We help you anticipate the next regulatory question — not react to it.
Active substance approvals and renewals under EU BPR. Endocrine disruptor assessment under EFSA/ECHA guidance, technical equivalence, and impurity relevancy reasoning — the scientific work that holds renewal dossiers together under peer review.
CPSRs signed by qualified Safety Assessors. Ingredient assessments to SCCS standard, NAM-based weight-of-evidence reasoning, and Responsible Person support across EU and UK markets.
Impurity qualification under ICH M7, nitrosamine risk assessment and CPCA reasoning, PDE/OEL derivation, and E&L safety qualification for medicinal products. ISO 10993-aligned biological evaluation and toxicological risk assessment for medical devices — aligned with the questions EU/MHRA and US FDA reviewers actually ask.